Barclays’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $459K | Buy |
|
|||||
|
2022
Q2 | $85K | Sell |
|
|||||
|
2022
Q1 | $196K | Sell |
|
|||||
|
2021
Q4 | $553K | Buy |
|
|||||
|
2021
Q3 | $498K | Buy |
|
|||||
|
2021
Q2 | $284K | Sell |
|
|||||
|
2021
Q1 | $853K | Sell |
|
|||||
|
2020
Q4 | $1.12M | Sell |
|
|||||
|
2020
Q3 | $1.53M | Sell |
|
|||||
|
2020
Q2 | $2.63M | Buy |
|
|||||
|
2020
Q1 | $424K | Sell |
|
|||||
|
2019
Q4 | $1.05M | Buy |
|
|||||
|
2019
Q3 | $584K | Sell |
|
|||||
|
2019
Q2 | $1.3M | Sell |
|
|||||
|
2019
Q1 | $2.35M | Buy |
|
|||||
|
2018
Q4 | $1.09M | Sell |
|
|||||
|
2018
Q3 | $2.38M | Buy |
|
|||||
|
2018
Q2 | $332K | Sell |
|
|||||
|
2018
Q1 | $816K | Buy |
|
|||||
|
2017
Q4 | $527K | Buy |
|
|||||
|
2017
Q3 | $277K | Buy |
|
|||||
|
2017
Q2 | $180K | Sell |
|
|||||
|
2017
Q1 | $2.12M | Buy |
|
|||||
|
2016
Q4 | $1.15M | Sell |
|
|||||
|
2016
Q3 | $9.25M | Buy |
|
|||||
|
2016
Q2 | $106K | Buy |
|
|||||
|
2016
Q1 | $70K | Sell |
|
|||||
|
2015
Q4 | $888K | Sell |
|
|||||
|
2015
Q3 | $3.1M | Buy |
|
|||||
|
2015
Q2 | $149K | Sell |
|
|||||
|
2015
Q1 | $935K | Buy |
|
|||||
|
2014
Q4 | $17K | Sell |
|
|||||
|
2014
Q3 | $96K | Buy |
|
|||||
|
2014
Q2 | $4K | Sell |
|
|||||
|
2014
Q1 | $6K | Buy |
|
|||||
|
2013
Q4 | $2K | Buy |
|